| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 157 |
| 1 | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | 118 |
| 2 | BUPIVACAINE HYDROCHLORIDE | 100 |
| 3 | BUPIVACAINE | 46 |
| 4 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | 46 |
| 5 | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE | 23 |
| 6 | METHOTREXATE | 20 |
| 7 | METHOTREXATE SODIUM | 20 |
| 8 | EPINEPHRINE | 19 |
| 9 | ADRENALINUM | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DIPHENHYDRAMINE HCI | 1 | 0.0833 |
| 1 | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | 118 | 0.0384 |
| 2 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | 46 | 0.0060 |
| 3 | BUPIVACAINE | 46 | 0.0049 |
| 4 | ROPIVACAINE HYDROCHLORIDE | 10 | 0.0041 |
| 5 | MEPIVACAINE HYDROCHLORIDE | 3 | 0.0026 |
| 6 | LIDOCAINE HCL 3% | 1 | 0.0022 |
| 7 | MENTHOL AND METHYL SALICYLATE | 1 | 0.0015 |
| 8 | SODIUM CHLORIDE 0.65% | 2 | 0.0013 |
| 9 | CAMPHOR, MENTHOL | 1 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 157 |
| 1 | Amide Local Anesthetic [EPC] | 51 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 20 |
| 3 | Catecholamine [EPC] | 19 |
| 4 | alpha-Adrenergic Agonist [EPC] | 19 |
| 5 | beta-Adrenergic Agonist [EPC] | 19 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 13 |
| 7 | Antiarrhythmic [EPC] | 7 |
| 8 | Corticosteroid [EPC] | 7 |
| 9 | Proton Pump Inhibitor [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0006 |
| 1 | Amide Local Anesthetic [EPC] | 51 | 0.0006 |
| 2 | Catecholamine [EPC] | 19 | 0.0002 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 157 | 0.0002 |
| 4 | Potassium-sparing Diuretic [EPC] | 1 | 0.0001 |
| 5 | Antiarrhythmic [EPC] | 7 | 0.0001 |
| 6 | Vitamin D Analog [EPC] | 1 | 0.0001 |
| 7 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 20 | 0.0000 |
| 9 | Purine Antimetabolite [EPC] | 4 | 0.0000 |